Alva Genomics
Private Company
Total funding raised: $2.5M
Overview
Alva Genomics is a Munich-based bioinformatics services firm offering specialized, custom analysis beyond standard pipelines for complex NGS data types. The company serves academic and industrial clients in genomics research, with demonstrated expertise in cancer genomics, immunology, and plant epigenetics. Its business model is built on project-based consulting, analysis, and training, supported by a small, experienced team. The company is privately held, revenue-generating, and has recently secured non-dilutive public funding for personnel development.
Technology Platform
Integrated service stack combining custom bioinformatics pipeline development, expertise in NGS data analysis (single-cell, spatial, epigenetics), and cloud-based execution primarily on Amazon AWS.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Alva Genomics competes in a fragmented bioinformatics services market against academic core facilities, freelance bioinformaticians, and larger contract research organizations (CROs). Its differentiation lies in deep biological insight, custom pipeline development, and a strong training/empowerment focus, positioning it as a premium partner for complex projects.